CONCLUSIONS: SARS-CoV-2 disrupts mitochondrial homeostasis and lipid metabolism in hepatocytes, promoting ferroptosis as a major contributor to virus-induced cytopathology. These findings suggest that ferroptosis may play a central role in COVID-19
Humanized virus suppressing factor-variant 13 (hzVSF-v13), a monoclonal IgG4 antibody, is a potential therapeutic candidate for COVID-19. Although fertility and embryonic developmental toxicity studies are crucial for the safety evaluation of new
The global pandemic caused by the SARS-CoV-2 virus, the etiologic agent for COVID-19, has produced a surge in the number of patients in hospitals, the increasing use of personal protective equipment (PPE), and the overload of the health care system
Albertans who have received two doses of an approved COVID-19 vaccine are encouraged to register online for a chance to win the last $1-million prize in Alberta’s vaccine lottery.
The COVID-19 pandemic continues to highlight the significant impact of pre-existing comorbidities on disease progression and patient outcomes due to the risk factors for severe disease in unvaccinated patients. We evaluated the association between
CONCLUSION: The temporary test centre successfully helped identify individuals with COVID-19 who exhibited mild disease symptoms. Healthcare providers should carefully consider the epidemiological and clinical characteristics of COVID-19 to arrange